Camptothecins: a review of their development and schedules of administration

This publication has 40 references indexed in Scilit:

• Phase I and pharmacokInetic (PK) study of Irinotecan (CPT11) with a prolonged (14D) infusion schedule
  European Journal Of Cancer, 1997
• Clinical Trials of Irinotecan Hydrochloride (CPT, Campto Injection, Topotecin Injection) in Japan^a
  Annals of the New York Academy of Sciences, 1996
• 9-Aminocamptothecin and Beyond.
  Annals of the New York Academy of Sciences, 1996
• CPT-11.
  Annals of the New York Academy of Sciences, 1996
• Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity
  Journal of Medicinal Chemistry, 1991
• Antitumor activity of a new camptothecin derivative, SN-22, against various murine tumors.
  Journal of Pharmacobio-Dynamics, 1987
• Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin
  Biochemical and Biophysical Research Communications, 1971
• Camptothecin inhibits macromolecular synthesis in mammalian cells but not in isolated mitochondria or lE. coli
  Biochemical and Biophysical Research Communications, 1970
• Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata^1,2
  Journal of the American Chemical Society, 1966